SPPLs as modifiers of the p53 pathway and methods of use

Details for Australian Patent Application No. 2004253884 (hide)

Owner Exelixis, Inc.

Inventors Nicoll, Monique; Belvin, Marcia; Friedman, Lori; Francis-Lang, Helen; Heuer, Timothy S.; Plowman, Gregory D.

Agent Davies Collison Cave

Pub. Number AU-A-2004253884

PCT Pub. Number WO2005/003306

Priority 60/479,769 19.06.03 US

Filing date 18 June 2004

Wipo publication date 13 January 2005

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2005/003306 Priority application(s): WO2005/003306

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004253888-Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases

2004253882-Methods and compositions for whole genome amplification and genotyping